YahooFinanceBusiness
On December 31, 2023, Glenview Capital Management, led by Larry Robbins (Trades, Portfolio), made a significant addition to its investment portfolio by acquiring 1,500,000 shares of Myriad Genetics Inc (NASDAQ:MYGN). This transaction, executed at a trade price of $19.14 per share, increased the fir